Article Figures & Data
Figures
- Figure 1
- Improvement (%) during follow-up (months) for the 2 groups. Improvement (%) during follow-up (months) for the 2 groups. VNS - Vagus nerve stimulation, CC - Corpus callosotomy
Tables
Patient characteristics Corpus callosotomy VNS P-value Number of patients 5 4 Age (years) 10.8±1.3 13.8±3.9 0.15 Male/female 4/1 0/4 0.02 Age of seizure onset (months) 20.6±30.6 18.8±20.5 0.68 Seizure duration before surgery (years) 8.2±3.1 12.0±3.6 0.13 Follow-up duration (months) 15.2±3.6 24.5±16.5 0.25 Mean age at surgery (years) 9.6±1.1 11.7±3.3 0.21 Length of surgery (minutes) 291.4±61.6 113.75±12.5 0.002 Length of hospitalization (days) 9.6±4.4 7.25±3.5 0.41 Main seizure types Atonic/tonic with head drops 5 2 Generalized tonic seizure 0 1 Generalized tonic–clonic seizure 0 1 MRI findings Atrophic change 0 2 Pachygyria–lissencephaly with band heterotopias 1 0 Normal 4 2 Number of antiepileptic medications Before surgery 3.4±1.1 3.5±1.3 0.91 After surgery 3.4±1.1 3.0±1.1 Change in antiepileptic medications Not changed 3 3 0.5 Increased 0 0 Decreased 2 1 VNS - Vagus nerve stimulation
- Table 2
- Comparison of seizure reduction rates (all seizure types) and documented complications of patients treated with corpus callosotomy and vagal nerve stimulation.
Seizure reduction rate Corpus callosotomy VNS Comparison p-value >75% 2 2 0.64 >51–74% 1 0 0.34 ≤50% 2 2 0.83 Complications 1/5 1/4 Cerebrospinal fluid 1 0 0.72 Swallowing difficulty 0 1 No 4 3 VNS - Vagus nerve stimulation
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.